SCHEMBL21326414

SCHEMBL21326414

[O-][S@+](Nc1ccccc1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
TDP1 Q9NUW8 3/20 0.36
HSD17B10 Q99714 2/20 0.36
CTSD P07339 1/20 0.36
TSHR P16473 3/20 0.35
PTGS2 P35354 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR2B P41595 1/20 0.35
MAPT P10636 4/20 0.34
IDO1 P14902 2/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8426023 1.00 ALDH1A1 (0.36) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL13690242 0.78 KIF11 (0.44) ALDH1A1HSD17B10TSHRALOX15MAPT
SCHEMBL13690236 0.78 PTGS1 (0.36) ALDH1A1TDP1HSD17B10TSHRL3MBTL1
SCHEMBL22700107 0.77 MAPT (0.44) ALDH1A1TDP1TSHRPTGS1MAPK1
SCHEMBL21034656 0.73 ALDH1A1 (0.41) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL2544869 0.72 ALDH1A1 (0.45) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL22700095 0.72 KMT2A (0.51) ALDH1A1TSHRALOX12MAPK1MAPT
SCHEMBL14812653 0.71 NPSR1 (0.33) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL20124844 0.69 ALDH1A1 (0.41) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL8278235 0.69 TDP1 (0.43) ALDH1A1TDP1HSD17B10CTSDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3535260-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AS FXR MODULATORS Hepagene Therapeutics, Inc. (VG) 2019-09-11 EP disclosed